Oluwasola Lawal

Oluwasola Lawal

Auto-generated profile, based on publicly available information

Oluwasola Lawal

Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2017 in Metabolomics
Verified
Journal Article
Open access
PDF file
OLOluwasola Lawal
Oluwasola Lawal
WAWaqar M. Ahmed
Waqar M. Ahmed
TNTamara M. E. Nijsen
Tamara M. E. Nijsen
RGRoyston Goodacre
Royston Goodacre
SFStephen J. Fowler
Stephen J. Fowler
Background The potential of exhaled breath sampling and analysis has long attracted interest in the areas of medical diagnosis and disease monitoring. This interest is attributed to its non-invasive nature, access to an unlimited sample supply (i.e., breath), and the potential to facilitate a rapid at patient diagnosis. However, progress from laboratory setting to routine clinical practice has been slow. Different methodologies of breath sampling, and the consequent difficulty in comparing and combining data, are considered to be a major contributor to this. To fulfil the potential of breath analysis within clinical and pre-clinical medicine, standardisation of some approaches to breath sampling and analysis will be beneficial. Objectives The aim of this review is to investigate the heterogeneity of breath sampling methods by performing an in depth bibliometric search to identify the current state of art in the area. In addition, the review will discuss and critique various breath sampling methods for off-line breath analysis. Methods Literature search was carried out in databases MEDLINE, BIOSIS, EMBASE, INSPEC, COMPENDEX, PQSCITECH, and SCISEARCH using the STN platform which delivers peer-reviewed articles. Keywords searched for include breath, sampling, collection, pre-concentration, volatile. Forward and reverse search was then performed on initially included articles. The breath collection methodologies of all included articles was subsequently reviewed. Results Sampling methods differs between research groups, for example regarding the portion of breath being targeted. Definition of late expiratory breath varies between studies. Conclusions Breath analysis is an interdisciplinary field of study using clinical, analytical chemistry, data processing, and metabolomics expertise. A move towards standardisation in breath sampling is currently being promoted within the breath research community with a view to harmonising analysis and thereby increasing robustness and inter-laboratory comparisons.

3 January 2017 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
OCon behalf of the BreathDx Consortium
on behalf of the BreathDx Consortium
POPouline Van Oort
Pouline Van Oort
TNTamara Nijsen
Tamara Nijsen
HWHans Weda
Hans Weda
HKHugo Knobel
Hugo Knobel
LBLieuwe Bos
Lieuwe Bos
The diagnosis of ventilator-associated pneumonia (VAP) remains time-consuming and costly, the clinical tools lack specificity and a bedside test to exclude infection in suspected patients is unavailable. Breath contains hundreds to thousands of volatile organic compounds (VOCs) that result from host and microbial metabolism as well as the environment. The present study aims to use breath VOC analysis to develop a model that can discriminate between patients who have positive cultures and who have negative cultures with a high sensitivity. The Molecular Analysis of Exhaled Breath as Diagnostic Test for Ventilator-Associated Pneumonia (BreathDx) study is a multicentre observational study. Breath and bronchial lavage samples will be collected from 100 and 53 intubated and ventilated patients suspected of VAP. Breath will be analysed using Thermal Desorption – Gas Chromatography – Mass Spectrometry (TD-GC-MS). The primary endpoint is the accuracy of cross-validated prediction for positive respiratory cultures in patients that are suspected of VAP, with a sensitivity of at least 99% (high negative predictive value). To our knowledge, BreathDx is the first study powered to investigate whether molecular analysis of breath can be used to classify suspected VAP patients with and without positive microbiological cultures with 99% sensitivity. UKCRN ID number 19086, registered May 2015; as well as registration at www.trialregister.nl under the acronym ‘BreathDx’ with trial ID number NTR 6114 (retrospectively registered on 28 October 2016).

13 September 2017 in ACS Infectious Diseases
Verified
Journal Article
Closed access
WAWaqar Ahmed
Waqar Ahmed
OLOluwasola Lawal
Oluwasola Lawal
TNTamara M. Nijsen
Tamara M. Nijsen
RGRoyston Goodacre
Royston Goodacre
SFStephen J. Fowler
Stephen J. Fowler

3 January 2018 in Journal of Breath Research
Verified
Journal Article
Closed access
PDF file
OLOluwasola Lawal
Oluwasola Lawal
HMHowbeer Muhamadali
Howbeer Muhamadali
WAWaqar Ahmed
Waqar Ahmed
IWIain R White
Iain R White
TNTamara M E Nijsen
Tamara M E Nijsen
SFStephen J Fowler
Stephen J Fowler
Ventilator-associated pneumonia (VAP) is a healthcare-acquired infection arising from the invasion of the lower respiratory tract by opportunistic pathogens in ventilated patients. The current method of diagnosis requires the culture of an airway sample such as bronchoalveolar lavage, which is invasive to obtain and may take up to seven days to identify a causal pathogen, or indeed rule out infection. While awaiting results, patients are administered empirical antibiotics; risks of this approach include lack of effect on the causal pathogen, contribution to the development of antibiotic resistance and downstream effects such as increased length of intensive care stay, cost, morbidity and mortality. Specific biomarkers which could identify causal pathogens in a timely manner are needed as they would allow judicious use of the most appropriate antimicrobial therapy. Volatile organic compound (VOC) analysis in exhaled breath is proposed as an alternative due to its non-invasive nature and its potential to provide rapid diagnosis at the patient’s bedside. VOCs in exhaled breath originate from exogenous, endogenous, as well as microbial sources. To identify potential markers, VAP-associated pathogens Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa , and Staphylococcus aureus were cultured in both artificial sputum medium and nutrient broth, and their headspaces were sampled and analysed for VOCs. Previously reported volatile markers were identified in this study, including indole and 1-undecene, alongside compounds that are novel to this investigation, cyclopentanone and 1-hexanol. We further investigated media components (substrates) to identify those that are essential for indole and cyclopentanone production, with potential implications for understanding microbial metabolism in the lung.

26 April 2018 in Metabolomics
Verified
Journal Article
Open access
PDF file
TCthe BreathDx consortium
the BreathDx consortium
OLOluwasola Lawal
Oluwasola Lawal
HKHugo Knobel
Hugo Knobel
HWHans Weda
Hans Weda
TNTamara M. E. Nijsen
Tamara M. E. Nijsen
SFStephen J. Fowler
Stephen J. Fowler
Introduction Infections such as ventilator-associated pneumonia (VAP) can be caused by one or more pathogens. Current methods for identifying these pathogenic microbes often require invasive sampling, and can be time consuming, due to the requirement for prolonged cultural enrichment along with selective and differential plating steps. This results in delays in diagnosis which in such critically ill patients can have potentially life-threatening consequences. Therefore, a non-invasive and timely diagnostic method is required. Detection of microbial volatile organic compounds (VOCs) in exhaled breath is proposed as an alternative method for identifying these pathogens and may distinguish between mono- and poly-microbial infections. Objectives To investigate volatile metabolites that discriminate between bacterial mono- and co-cultures. Methods VAP-associated pathogens Enterobacter cloacae and Pseudomonas aeruginosa were cultured individually and together in artificial sputum medium for 24 h and their headspace was analysed for potential discriminatory VOCs by thermal desorption gas chromatography–mass spectrometry. Results Of the 70 VOCs putatively identified, 23 were found to significantly increase during bacterial culture (i.e. likely to be released during metabolism) and 13 decreased (i.e. likely consumed during metabolism). The other VOCs showed no transformation (similar concentrations observed as in the medium). Bacteria-specific VOCs including 2-methyl-1-propanol, 2-phenylethanol, and 3-methyl-1-butanol were observed in the headspace of axenic cultures of E. cloacae, and methyl 2-ethylhexanoate in the headspace of P. aeruginosa cultures which is novel to this investigation. Previously reported VOCs 1-undecene and pyrrole were also detected. The metabolites 2-methylbutyl acetate and methyl 2-methylbutyrate, which are reported to exhibit antimicrobial activity, were elevated in co-culture only. Conclusion The observed VOCs were able to differentiate axenic and co-cultures. Validation of these markers in exhaled breath specimens could prove useful for timely pathogen identification and infection type diagnosis.

1 June 2018 in The Analyst
Verified
Journal Article
Closed access
PDF file
OLOluwasola Lawal
Oluwasola Lawal
HKHugo Knobel
Hugo Knobel
HWHans Weda
Hans Weda
LBLieuwe Bos
Lieuwe Bos
TNTamara M. E. Nijsen
Tamara M. E. Nijsen
SFStephen J. Fowler
Stephen J. Fowler
Bacteria are found ubiquitously within and on nearly every site within humans, including the airways. Microbes interact with airway epithelial cells in lung infections such as ventilator-associated pneumonia (VAP). Development of infection results in the production of oxidants such as hydrogen peroxide that may further damage the epithelium. VAP is difficult to diagnose and associated with significant mortality. Current methods are invasive and time consuming impacting on appropriate therapy, antimicrobial resistance and financial costs. Volatile organic compound (VOC) analysis in exhaled breath is proposed as a tool for early detection due to its non-invasive property and potential to facilitate timely diagnosis. To investigate potential early VOC markers, A549 epithelial cells that were originally isolated from human alveoli were cultured with and without Pseudomonas aeruginosa, and the headspace of the culture vessel analysed using sorbent-based capture of VOCs followed by thermal desorption-gas chromatography-mass spectrometry (TD-GC-MS) in order to identify potential discriminatory VOCs. A549 cells were also cultured with hydrogen peroxide to induce oxidative stress in order to investigate potential biomarkers of epithelial cell damage. Previously reported VOCs including acetone and ethanol were observed from the infection experiment along with novel bacterial markers, which we identified as mostly ether based compounds. Alkanes such as decane and octane were also found to be elevated after hydrogen peroxide treatment of A549 cells, likely as a result of peroxidation of oleic acids.